{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:14Z","timestamp":1787026274799,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903845"],"award-info":[{"award-number":["81903845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21702051"],"award-info":[{"award-number":["21702051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773766"],"award-info":[{"award-number":["81773766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20181330"],"award-info":[{"award-number":["BK20181330"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"DOI":"10.3389\/fchem.2019.00820","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T23:27:06Z","timestamp":1576711626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance"],"prefix":"10.3389","volume":"7","author":[{"given":"Xingping","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int."},{"key":"B2","first-page":"6365","article-title":"Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage","volume":"48","author":"Bellamy","year":"1988","journal-title":"Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0014-4827(91)90452-Z","article-title":"Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative","volume":"196","author":"Boesch","year":"1991","journal-title":"Exp. Cell Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/jat.3470","article-title":"The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review","volume":"37","author":"Cao","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/bcpt.12108","article-title":"Sustained increase in the oral bioavailability of loperamide after a single oral dose of HM30181, a P-glycoprotein Inhibitor, in healthy male participants","volume":"113","author":"Cha","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1200\/JCO.2001.19.3.832","article-title":"Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833","volume":"19","author":"Chico","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"B8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-1-60761-416-6_15","article-title":"Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors","volume":"596","author":"Coley","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"B9","first-page":"854","article-title":"Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities","volume":"290","author":"Dantzig","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1432-1033.1995.tb20352.x","article-title":"Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability","volume":"228","author":"Drori","year":"2010","journal-title":"FEBS J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ejps.2018.08.018","article-title":"Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo","volume":"123","author":"Du","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e7415","DOI":"10.1371\/journal.pone.0007415","article-title":"NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance","volume":"4","author":"Duan","year":"2009","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/jm300117u","article-title":"Synthesis and evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer","volume":"55","author":"Duan","year":"2012","journal-title":"J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/00001813-200410000-00006","article-title":"Ex vivo reversal of chemoresistance by tariquidar (XR9576)","volume":"15","author":"Federica","year":"2004","journal-title":"Anticancer. Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fphar.2018.00021","article-title":"Silibinin inhibits NSCLC metastasis by targeting the EGFR\/LOX pathway","volume":"9","author":"Hou","year":"","journal-title":"Front. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3892\/ijmm.2018.3502","article-title":"The antitumor activity screening of chemical constituents from Camellia nitidissima Chi","volume":"41","author":"Hou","year":"","journal-title":"Int. J. Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13887","DOI":"10.1021\/bi991115m","article-title":"Both ATP sites of human P-glycoprotein are essential but not symmetric","volume":"38","author":"Hrycyna","year":"1999","journal-title":"Biochemistry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0928-0987(00)00215-3","article-title":"Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport","volume":"12","author":"Katoh","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1021\/acs.jmedchem.5b00188","article-title":"HM30181 derivatives as novel potent and selective inhibitors of the breast cancer resistance protein (BCRP\/ABCG2)","volume":"58","author":"K\u00f6hler","year":"2015","journal-title":"J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1042\/BST20150047","article-title":"Structural basis for the mechanism of ABC transporters","volume":"43","author":"Konstantinos","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1158\/1078-0432.CCR-15-1762","article-title":"Personalized pre-clinical trials in BRAF inhibitor resistant patient derived xenograft models of melanoma identify c-Met as an effective second line combination therapy target","volume":"75","author":"Krepler","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer-mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","article-title":"Natural products as multidrug resistance modulators in cancer","volume":"176","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1349-7006.1998.tb00518.x","article-title":"Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein","volume":"89","author":"Kusunoki","year":"2010","journal-title":"Cancer Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7972","DOI":"10.1016\/j.bmc.2006.07.055","article-title":"In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450","volume":"14","author":"Labrie","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1021\/jo00819a045","article-title":"Absolute configuration of the phenyl 2-piperidylcarbinols","volume":"36","author":"Lapidus","year":"1971","journal-title":"J. Organic Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s10637-015-0205-y","article-title":"The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations","volume":"33","author":"Mathias","year":"2015","journal-title":"Invest. New Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.clpt.2003.10.008","article-title":"Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens","volume":"75","author":"Oliver","year":"2004","journal-title":"Clin. Pharm. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02351067","article-title":"Dexverapamil as resistance modifier in acute myeloid leukaemia","volume":"3","author":"Pirker","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0006-2952(96)00826-X","article-title":"Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein","volume":"53","author":"Shapiro","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1042\/bj3080381","article-title":"Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells","volume":"308","author":"Sharom","year":"1995","journal-title":"Biochem. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ijc.10792","article-title":"Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979","volume":"103","author":"Shepard","year":"2003","journal-title":"Int. J. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7308","DOI":"10.1021\/jo0345502","article-title":"erythro-1-Naphthyl-1-(2-piperidyl)methanol: synthesis, resolution, NMR relative configuration, and VCD absolute configuration","volume":"68","author":"Solladi\u00e9-Cavallo","year":"2003","journal-title":"J. Org. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1007\/BF02351063","article-title":"Dexverapamil to overcome epirubicin resistance in advanced breast cancer","volume":"121","author":"Th\u00fcrlimann","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/ard.2007.070821","article-title":"Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis","volume":"67","author":"Tsujimura","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/jpet.115.229393","article-title":"Factors influencing the central nervous system distribution of a novel phosphoinositide 3-kinase\/mammalian target of rapamycin inhibitor GSK2126458: implications for overcoming resistance with combination therapy for melanoma brain metastases","volume":"356","author":"Vaidhyanathan","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1043-6618(03)00158-0","article-title":"P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement","volume":"48","author":"Varma","year":"2003","journal-title":"Pharmacol. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/js980082d","article-title":"Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics","volume":"87","author":"Wacher","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"B42","first-page":"522","article-title":"In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein","volume":"28","author":"Wang","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"B43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0169-409X(97)00041-0","article-title":"The barrier function of CYP3A4 and P-glycoprotein in the small bowel","volume":"27","author":"Watkins","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.phymed.2018.09.003","article-title":"DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK\/mTOR signaling pathway","volume":"54","author":"Wei","year":"2019","journal-title":"Phytomedicine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ygyno.2015.02.002","article-title":"NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo","volume":"137","author":"Yang","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1038\/bjc.2014.254","article-title":"Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925","volume":"110","author":"Yang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B48","first-page":"5002","article-title":"Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562\/ADM cells","volume":"49","author":"Yusa","year":"1989","journal-title":"Cancer Res."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2019.00820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T11:14:36Z","timestamp":1576754076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2019.00820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":48,"alternative-id":["10.3389\/fchem.2019.00820"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2019.00820","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"article-number":"820"}}